Harrow Inc HROWL:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 03/28/24 EDT
25.15UNCH (UNCH)
Volume
4,667
52 week range
22.05 - 25.25
Loading...
  • Open25.05
  • Day High25.14
  • Day Low25.02
  • Prev Close25.05
  • 52 Week High25.25
  • 52 Week High Date07/10/23
  • 52 Week Low22.05
  • 52 Week Low Date11/14/23

Key Stats

  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume0.01M
  • Dividend2.16
  • Dividend Yield8.57%
  • Beta-
  • YTD % Change4.63

KEY STATS

  • Open25.05
  • Day High25.14
  • Day Low25.02
  • Prev Close25.05
  • 52 Week High25.25
  • 52 Week High Date07/10/23
  • 52 Week Low22.05
  • 52 Week Low Date11/14/23
  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume0.01M
  • Dividend2.16
  • Dividend Yield8.57%
  • Beta-
  • YTD % Change4.63

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date01/11/2024
  • Div Amount0.5391
  • Split Date-
  • Split Factor-

Latest On Harrow Inc

 

Profile

MORE
Harrow, Inc. is an eyecare pharmaceutical company. The Company is engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the United States market. It provides a comprehensive portfolio of prescription and non-prescription pharmaceutical products. It owns commercial rights to portfolios of branded ophthalmic pharmaceutical products in North America, all of which are marketed under the Harrow name. It owns and operates ImprimisRx...
Mark Baum J.D.
Chairman of the Board, Chief Executive Officer
Andrew Boll
Chief Financial Officer, Corporate Secretary
Address
102 WOODMONT BLVD, SUITE 610
Nashville, TN
37215
United States